Skip to content
2000
image of A Recent Progress in Biological Activities of 1,3,4-thiadiazole and its Derivatives: A Review

Abstract

1,3,4-thiadiazole can be produced in several ways and has a wide range of possible biological uses. As a result, scientists have created novel procedures for producing 1,3,4-thiadiazole derivatives and their use in medicine. Among the activities are Anticancer, anticonvulsant, antimicrobial, antifungal, antiinflammatory, antiHIV, antidiabetic, antitubercular, antifungal, and other properties. We have compiled different biological activities of 1,3,4-thiadazole in this review study. Many researchers may find the material on this page helpful, which could result in the identification of new medicinal species beneficial to society.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266344588241127031534
2025-01-30
2025-04-05
Loading full text...

Full text loading...

References

  1. Szeliga M. Thiadiazole derivatives as anticancer agents. Pharmacol. Rep. 2020 72 5 1079 1100 10.1007/s43440‑020‑00154‑7 32880874
    [Google Scholar]
  2. Obakachi V.A. Kushwaha B. Kushwaha N.D. Mokoena S. Ganai A.M. Pathan T.K. van Zyl W.E. Karpoormath R. Synthetic and anti-cancer activity aspects of 1, 3, 4-thiadiazole containing bioactive molecules: A concise review. J. Sulfur Chem. 2021 42 6 670 691 10.1080/17415993.2021.1963441
    [Google Scholar]
  3. Raj V Rai A Saha S Human cancer cell line based approach of 1,3,4-thiadiazole and its fused ring: A comprehensive review. Anticancer Agents Med Chem 2017 17 4 500 523
    [Google Scholar]
  4. Chakraborty S Rahman T The difficulties in cancer treatment. Ecancermedicalscience 2012 6 16
    [Google Scholar]
  5. Sahoo B. Dinda S. Kumar B. Panda J. Brahmkshatriya P. Molecular docking study, green synthesis and pharmacological evaluation of 1,3,4-thiadiazole derivatives as potential antiepileptic agents. Mini Rev. Med. Chem. 2013 13 14 2076 2081 10.2174/13895575113136660099 24144260
    [Google Scholar]
  6. Anthwal T. Nain S. 1, 3, 4-thiadiazole scaffold: As anti-epileptic agents. Front Chem. 2022 9 671212 10.3389/fchem.2021.671212 35127639
    [Google Scholar]
  7. Sharma B. Verma A. Prajapati S. Sharma U.K. Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles. Int. J. Med. Chem. 2013 2013 1 1 16 10.1155/2013/348948 25405032
    [Google Scholar]
  8. Othman A.A. Kihel M. Amara S. 1,3,4-Oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arab. J. Chem. 2019 12 7 1660 1675 10.1016/j.arabjc.2014.09.003
    [Google Scholar]
  9. Serban G. Stanasel O. Serban E. Bota S. 2-Amino-1,3,4-thiadiazole as a potential scaffold for promising antimicrobial agents. Drug Des. Devel. Ther. 2018 12 1545 1566 10.2147/DDDT.S155958 29910602
    [Google Scholar]
  10. Altıntop MD Sever B Özdemir A Ilgın S Atlı Ö Turan-Zitouni G Kaplancıklı ZA Synthesis and evaluation of a series of 1,3,4-Thiadiazole derivatives as potential anticancer agents. Anticancer Agents Med Chem 2018 18 11 1606 1616
    [Google Scholar]
  11. Gowramma B. Praveen T.K. Gomathy S. Kalirajan R. Babu B. Krishnavenic N. Synthesis of 2-(Bis (2-Chloroethyl)Amino)-N-(5-Substitutedphenyl)- 1,3,4- Thiadiazol-2-Yl)Acetohydrazide And Evaluation of Anticancer Activity. Curr. Bioact. Compd. 2018 14 3 309 316 10.2174/1573407213666170428110528
    [Google Scholar]
  12. Song X.J. Shao Y. Dong X.G. Microwave-assisted synthesis of some novel fluorinated pyrazolo[3,4-d]pyrimidine derivatives containing 1,3,4-thiadiazole as potential antitumor agents. Chin. Chem. Lett. 2011 22 9 1036 1038 10.1016/j.cclet.2011.05.012
    [Google Scholar]
  13. Krishna S. Gowramma B. Mohammed M. Kalirajan R. Kaviarasan L. Praveen T.K. Synthesis, In Silico and In Vivo Evaluation of Novel 1, 3, 4-Thiadiazole Analogues as Novel Anticancer Agents. Lett. Drug Des. Discov. 2020 17 4 434 444 10.2174/1570180816666190710145939
    [Google Scholar]
  14. Abouzied A.S. Al-Humaidi J.Y. Bazaid A.S. Qanash H. Binsaleh N.K. Alamri A. Ibrahim S.M. Gomha S.M. Synthesis, molecular docking study, and cytotoxicity evaluation of some novel 1, 3, 4-thiadiazole as well as 1, 3-thiazole derivatives bearing a pyridine moiety. Molecules 2022 27 19 6368 10.3390/molecules27196368 36234908
    [Google Scholar]
  15. Yadagiri B. Gurrala S. Bantu R. Nagarapu L. Polepalli S. Srujana G. Jain N. Synthesis and evaluation of benzosuberone embedded with 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole moieties as new potential anti proliferative agents. Bioorg. Med. Chem. Lett. 2015 25 10 2220 2224 10.1016/j.bmcl.2015.03.032 25827522
    [Google Scholar]
  16. Zhang K. Wang P. Xuan L.N. Fu X.Y. Jing F. Li S. Liu Y.M. Chen B.Q. Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety. Bioorg. Med. Chem. Lett. 2014 24 22 5154 5156 10.1016/j.bmcl.2014.09.086 25442303
    [Google Scholar]
  17. Matysiak J. Nasulewicz A. Pełczyńska M. Świtalska M. Jaroszewicz I. Opolski A. Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Eur. J. Med. Chem. 2006 41 4 475 482 10.1016/j.ejmech.2005.12.007 16517026
    [Google Scholar]
  18. Tegginamath G. Kamble R.R. Taj T. Kattimani P.P. Meti G.Y. Synthesis of novel imidazo[2,1-b][1,3,4]thiadiazoles appended to sydnone as anticancer agents. Med. Chem. Res. 2013 22 9 4367 4375 10.1007/s00044‑012‑0441‑z
    [Google Scholar]
  19. Carbone D. Pecoraro C. Panzeca G. Xu G. Roeten M.S.F. Cascioferro S. Giovannetti E. Diana P. Parrino B. 1,3,4-Oxadiazole and 1,3,4-Thiadiazole nortopsentin derivatives against pancreatic ductal adenocarcinoma: Synthesis, cytotoxic activity, and inhibition of CDK1. Mar. Drugs 2023 21 7 412 10.3390/md21070412 37504943
    [Google Scholar]
  20. Cascioferro S. Li Petri G. Parrino B. El Hassouni B. Carbone D. Arizza V. Perricone U. Padova A. Funel N. Peters G.J. Cirrincione G. Giovannetti E. Diana P. 3-(6-Phenylimidazo [2, 1-b][1, 3, 4] thiadiazol-2-yl)-1 H-indole derivatives as new anticancer agents in the treatment of pancreatic ductal adenocarcinoma. Molecules 2020 25 2 329 10.3390/molecules25020329 31947550
    [Google Scholar]
  21. Patel H.M. Sing B. Bhardwaj V. Palkar M. Shaikh M.S. Rane R. Alwan W.S. Gadad A.K. Noolvi M.N. Karpoormath R. Design, synthesis and evaluation of small molecule imidazo[2,1-b][1,3,4]thiadiazoles as inhibitors of transforming growth factor-β type-I receptor kinase (ALK5). Eur. J. Med. Chem. 2015 93 599 613 10.1016/j.ejmech.2014.09.002 25234355
    [Google Scholar]
  22. Kaviarasan L. Gowramma B. Kalirajan R. Mevithra M. Chandralekha S. Molecular docking studies and synthesis of a new class of chroman-4-one fused 1, 3, 4-thiadiazole derivatives and evaluation for their anticancer potential. J. Indian Chem. Soc. 2020 17 2083 2094
    [Google Scholar]
  23. Sarafroz M. Khatoon Y. Ahmad N. Amir M. Salahuddin S. Hyder Pottoo F. Synthesis, characterization and anticonvulsant activity of novel fused 1, 2, 4-triazolo-1, 3, 4-thiadiazoles. Orient. J. Chem. 2019 35 1 64 70 10.13005/ojc/350107
    [Google Scholar]
  24. Aliyu A. Idris A.Y. Musa A.M. Hamza A.N. Ahmadu J.O. Shehu A. Salisu A. Design, synthesis and in-vivo anticonvulsant evaluation of 5-[(E)-(3, 4, 5-trimethoxybenzylidene) amino]-1, 3, 4-thiadiazole-2-thiol. Int. J. Glob. Sci. Sustain 2021 7 2 8
    [Google Scholar]
  25. Bhattacharya S. Kashaw V. Design, synthesis and anticonvulsant potential of (E)-3-(5-(substituted aminomethyl)-1, 3, 4-thiadiazol-2-yl)-2-substituted styrylquinazolin-4-(3H)-one. J. Drug Deliv. Ther. 2019 9 2 591 602
    [Google Scholar]
  26. Chapleo C.B. Myers M. Myers P.L. Saville J.F. Smith A.C.B. Stillings M.R. Tulloch I.F. Walter D.S. Welbourn A.P. Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 1. Hydrazines. J. Med. Chem. 1986 29 11 2273 2280 10.1021/jm00161a024 3783589
    [Google Scholar]
  27. Diaz J.R.A. Camí G.E. Liu-González M. Vega D.R. Vullo D. Juárez A. Pedregosa J.C. Supuran C.T. Salts of 5-amino-2-sulfonamide-1,3,4-thiadiazole, a structural and analog of acetazolamide, show interesting carbonic anhydrase inhibitory properties, diuretic, and anticonvulsant action. J. Enzyme Inhib. Med. Chem. 2016 31 6 1102 1110 10.3109/14756366.2015.1096270 26497704
    [Google Scholar]
  28. Dogan H.N. Duran A. Rollas S. Sener G. Uysal M.K. Gülen D. Synthesis of new 2,5-Disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities. Bioorg. Med. Chem. 2002 10 9 2893 2898 10.1016/S0968‑0896(02)00143‑8 12110309
    [Google Scholar]
  29. Foroumadi A. Sheibani V. Sakhteman A. Rameshk M. Abbasi M. Farazifard R. Tabatabai S.A. Shafiee A. Synthesis and anticonvulsant activity of novel 2-amino-5-[4-chloro-2-(2-chlorophenoxy) phenyl]-1, 3, 4-thiadiazole derivatives. Daru 2007 15 2 89 93
    [Google Scholar]
  30. Foroumadi A. Tabatabai S.A. Gitinezhad G. Zarrindast M.R. Shafiee A. Synthesis and anticonvulsant activity of 5-Aryl-1,3,4-thiadiazole derivatives. Pharm. Pharmacol. Commun. 2000 6 1 31 33 10.1211/146080800128735430
    [Google Scholar]
  31. Husain A. Naseer M.A. Sarafroz M. Synthesis and anticonvulsant activity of some novel fused heterocyclic 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives. Acta Pol. Pharm. 2009 66 2 135 140 19719046
    [Google Scholar]
  32. Jatav V. Mishra P. Kashaw S. Stables J.P. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur. J. Med. Chem. 2008 43 9 1945 1954 10.1016/j.ejmech.2007.12.003 18222569
    [Google Scholar]
  33. Karakus S. Koçyığıt-Kaymakcioğlu B. Toklu H.Z. Aricioglu F. Rollas S. Synthesis and anticonvulsant activity of new N ‐(Alkyl/Sub‐stituted aryl)‐ N ′‐[4‐(5‐cyclohexylamino)‐1,3,4‐thiadiazole‐2‐yl)phenyl]thioureas. Arch. Pharm. (Weinheim) 2009 342 1 48 53 10.1002/ardp.200800118 19035387
    [Google Scholar]
  34. Stillings M.R. Welbourn A.P. Walter D.S. Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 2. Aminoalkyl derivatives. J. Med. Chem. 1986 29 11 2280 2284 10.1021/jm00161a025 3783590
    [Google Scholar]
  35. Luszczki J.J. Karpińska M. Matysiak J. Niewiadomy A. Characterization and preliminary anticonvulsant assessment of some 1,3,4-thiadiazole derivatives. Pharmacol. Rep. 2015 67 3 588 592 10.1016/j.pharep.2014.12.008 25933973
    [Google Scholar]
  36. Farghaly T. Abdallah M. Aziz M. Synthesis and antimicrobial activity of some new 1,3,4-thiadiazole derivatives. Molecules 2012 17 12 14625 14636 10.3390/molecules171214625 23222925
    [Google Scholar]
  37. Sayiner H.S. Yilmazer M.I. Abdelsalam A.T. Ganim M.A. Baloglu C. Altunoglu Y.C. Gür M. Saracoglu M. Attia M.S. Mahmoud S.A. Mohamed E.H. Boukherroub R. Al-Shaalan N.H. Alharthi S. Kandemirli F. Amin M.A. Synthesis and characterization of new 1,3,4-thiadiazole derivatives: Study of their antibacterial activity and CT-DNA binding. RSC Advances 2022 12 46 29627 29639 10.1039/D2RA02435G 36321093
    [Google Scholar]
  38. Gowramma B. Gomaty S. Kalirajan R. Synthesis, characterisation and antimicrobial evaluations of some novel 1, 3, 4-thiadiazole derivatives. Int. J. Pharm. Sci. Res. 2011 2 6 1476
    [Google Scholar]
  39. Mohamed A.E. Elgammal W.E. Dawaba A.M. Ibrahim A.G. Fouda A. Hassan S.M. A novel 1,3,4-thiadiazole modified chitosan: synthesis, characterization, antimicrobial activity, and release study from film dressings. Appl. Biol. Chem. 2022 65 1 54 10.1186/s13765‑022‑00725‑7
    [Google Scholar]
  40. Hamad S.F. Ibraheem T.K. Synthesis, characterize and antibacterial evaluate of some novel compounds containing 1, 3, 4-thiadiazole. J. Pharm. Negat. Results 2022 ••• 1119 1122
    [Google Scholar]
  41. Güzeldemirci N.U. Küçükbasmacı Ö. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. Eur. J. Med. Chem. 2010 45 1 63 68 10.1016/j.ejmech.2009.09.024 19939519
    [Google Scholar]
  42. Palekar V.S. Damle A.J. Shukla S.R. Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide. Eur. J. Med. Chem. 2009 44 12 5112 5116 10.1016/j.ejmech.2009.07.023 19683841
    [Google Scholar]
  43. Pintilie O. Profire L. Sunel V. Popa M. Pui A. Synthesis and antimicrobial activity of some new 1,3,4-thiadiazole and 1,2,4-triazole compounds having a D,L-methionine moiety. Molecules 2007 12 1 103 113 10.3390/12010103 17693957
    [Google Scholar]
  44. Khalili Ghomi M. Noori M. Nazari Montazer M. Zomorodian K. Dastyafteh N. Yazdanpanah S. Sayahi M.H. Javanshir S. Nouri A. Asadi M. Badali H. Larijani B. Irajie C. Iraji A. Mahdavi M. [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: Design, synthesis, pharmacological evaluations, and in silico studies. Sci. Rep. 2023 13 1 10136 10.1038/s41598‑023‑37203‑z 37349372
    [Google Scholar]
  45. Amir M Kumar A Ali I Khan SA ChemInform abstract: Synthesis of pharmaceutically important 1,3,4-thiadiazole and imidazolinone derivatives as antimicrobials ChemInform 2010 41 1
    [Google Scholar]
  46. Invidiata FP Simoni D Scintu F Pinna N 3,6-Disubstituted 1, 2, 4-triazolo [3, 4-b][1, 3, 4] thiadiazoles: Synthesis, antimicrobial and antiviral activity. II. Farmaco 1996 51 10 659 654
    [Google Scholar]
  47. Invidiata FP Furno G Simoni D Lampronti I Musiu C Milia C Scintu F La Colla P 3, 6-Disubstituted 1, 2, 4-triazolo [3, 4-b][1, 3, 4] thiadiazoles: Synthesis and evaluation for antimicrobial and antiviral activity. Farmaco 1997 52 4 259 261
    [Google Scholar]
  48. Demirbas A. Sahin D. Demirbas N. Karaoglu S.A. Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities. Eur. J. Med. Chem. 2009 44 7 2896 2903 10.1016/j.ejmech.2008.12.005 19167136
    [Google Scholar]
  49. Patil S. Yadav A. Birajdar R. Kane S. Mohite S. Magdum C. Microwave assisted synthesis, molecular docking studies of new N-{[5-(Phenyl)-1, 3, 4-Thiadiazole-2-Yl] Carbamothioyl} derivatives as potent antimicrobial agents. JUSST. 2020 22 11 1095 1113
    [Google Scholar]
  50. Yan S.L. Yang M.Y. Sun Z.H. Min L.J. Tan C.X. Weng J.Q. Wu H.K. Liu X.H. Synthesis and antifungal activity of 1, 2, 3-thiadiazole derivatives containing 1, 3, 4-thiadiazole moiety. Lett. Drug Des. Discov. 2014 11 7 940 943 10.2174/1570180811666140423222141
    [Google Scholar]
  51. Zhang L.J. Yang M.Y. Sun Z.H. Tan C.X. Weng J.Q. Wu H.K. Liu X.H. Synthesis and antifungal activity of 1, 3, 4-thiadiazole derivatives containing pyridine group. Lett. Drug Des. Discov. 2014 11 9 1107 1111 10.2174/1570180811666140610212731
    [Google Scholar]
  52. Tang C. Chen X. Yang S. Guo W. Yang X. Li P. Wang X. Discovery of novel carbazole derivatives containing a 1,3,4-thiadiazole moiety as antifungal candidates. Phosphorus Sulfur Silicon Relat. Elem. 2023 198 8 627 631 10.1080/10426507.2023.2191961
    [Google Scholar]
  53. Dróżdż A. Kubera D. Sławińska-Brych A. Synergistic antifungal interactions between antibiotic Amphotericin B and selected 1,3,4-thiadiazole derivatives, determined by microbiological, cytochemical, and molecular spectroscopic studies Int. J. Mol. Sci. 2023 24 3430
    [Google Scholar]
  54. Shi H. Li L. Song D. Zheng Y. Wu Z. In vitro/vivo antifungal activity study of novel mandelic acid derivatives as potential fungicides against Thanatephorus cucumeris. Arab. J. Chem. 2023 16 8 104884 10.1016/j.arabjc.2023.104884
    [Google Scholar]
  55. Chudzik B. Bonio K. Dabrowski W. Pietrzak D. Niewiadomy A. Olender A. Malodobry K. Gagoś M. Synergistic antifungal interactions of amphotericin B with 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol. Sci. Rep. 2019 9 1 12945 10.1038/s41598‑019‑49425‑1 31506532
    [Google Scholar]
  56. Chudzik B. Bonio K. Dabrowski W. Pietrzak D. Niewiadomy A. Olender A. Pawlikowska-Pawlęga B. Gagoś M. Antifungal effects of a 1,3,4-thiadiazole derivative determined by cytochemical and vibrational spectroscopic studies. PLoS One 2019 14 9 e0222775 10.1371/journal.pone.0222775 31568502
    [Google Scholar]
  57. Matysiak J. Malinski Z. [2-(2,4-Dihydroxyphenyl)-1,3,4-thiadiazole analogues: Antifungal activity in vitro against Candida species]. Bioorg. Khim. 2007 33 6 640 647 18173128
    [Google Scholar]
  58. Chen C.J. Song B.A. Yang S. Xu G.F. Bhadury P.S. Jin L.H. Hu D.Y. Li Q.Z. Liu F. Xue W. Lu P. Chen Z. Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives. Bioorg. Med. Chem. 2007 15 12 3981 3989 10.1016/j.bmc.2007.04.014 17452108
    [Google Scholar]
  59. Zhan W. Zhou R. Mao P. Yuan C. Zhang T. Liu Y. Tian J. Wang H. Xue W. Synthesis, antifungal activity and mechanism of action of novel chalcone derivatives containing 1, 2, 4-triazolo-[3, 4-b]-1, 3, 4-thiadiazole. Mol. Divers. 2023 1 4 36964852
    [Google Scholar]
  60. Chen M. Duan W.G. Lin G.S. Fan Z.T. Wang X. Synthesis, antifungal activity, and 3D-QSAR study of novel nopol-derived 1, 3, 4-thiadiazole-thiourea compounds. Molecules 2021 26 6 1708 10.3390/molecules26061708 33803890
    [Google Scholar]
  61. Zou R. Li B. Duan W. Lin G. Cui Y. Synthesis of 3‐carene ‐derived nanocellulose/1,3, 4‐thiadiazole‐amide complexes with antifungal activity for plant protection. Pest Manag. Sci. 2022 78 8 3277 3286 10.1002/ps.6952 35484724
    [Google Scholar]
  62. Gowramma B. Praveen T.K. Kalirajan R. Babu B. Synthesis of some novel 2-azetidinones/4-thiazolidinones bearing 1, 3, 4-thiadiazole nucleus and screening for its anti-imflammatory activity. Lett. Drug Des. Discov. 2016 13 7 676 683 10.2174/1570180813666151123235546
    [Google Scholar]
  63. Schenone S. Brullo C. Bruno O. Bondavalli F. Ranise A. Filippelli W. Rinaldi B. Capuano A. Falcone G. New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities. Bioorg. Med. Chem. 2006 14 6 1698 1705 10.1016/j.bmc.2005.10.064 16310359
    [Google Scholar]
  64. Chawla G. Kumar U. Bawa S. Kumar J. Syntheses and evaluation of anti-inflammatory, analgesic and ulcerogenic activities of 1,3,4-oxadiazole and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. J. Enzyme Inhib. Med. Chem. 2012 27 5 658 665 10.3109/14756366.2011.606543 21899490
    [Google Scholar]
  65. Kadi A.A. Al-Abdullah E.S. Shehata I.A. Habib E.E. Ibrahim T.M. El-Emam A.A. Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives. Eur. J. Med. Chem. 2010 45 11 5006 5011 10.1016/j.ejmech.2010.08.007 20801553
    [Google Scholar]
  66. Maddila S. Gorle S. Singh M. Lavanya P.B. Jonnalagadda S. Synthesis and anti-inflammatory activity of fused 1, 2, 4-triazolo-[3, 4-b][1, 3, 4] thiadiazole derivatives of phenothiazine. Lett. Drug Des. Discov. 2013 10 10 977 983 10.2174/15701808113109990034
    [Google Scholar]
  67. Maddila S. Gorle S. Sampath C. Lavanya P. Synthesis and anti-inflammatory activity of some new 1,3,4-thiadiazoles containing pyrazole and pyrrole nucleus. J. Saudi Chem. Soc. 2016 20 S306 S312 10.1016/j.jscs.2012.11.007
    [Google Scholar]
  68. Labanauskas L. Kalcas V. Udrenaite E. Gaidelis P. Brukstus A. Dauksas V. Synthesis of 3-(3,4-dimethoxyphenyl)-1 H-1,2,4-triazole-5-thiol and 2-amino-5-(3,4-dimethoxyphenyl)-1,3,4-thiadiazole derivatives exhibiting anti-inflammatory activity. Pharmazie 2001 56 8 617 619 11534336
    [Google Scholar]
  69. Bhosale M. Yadav A. Magdum C. Mohite S. Molecular docking studies, synthesis, toxicological evaluation using brine shrimp (Artemia salina L.) model and anti-inflammatory activity of some N-(substituted)-5-phenyl-1, 3, 4-thiadiazol-2-amine derivatives. Int. J. Sci. Res. Sci. Technol. 2020 7 5 51 62 10.32628/IJSRST207515
    [Google Scholar]
  70. Tozkoparan B. Peri Aytac S. Gursoy S. Gunal S. Aktay G. Novel 1, 2, 4-Triazolo [3, 4-b]-1, 3, 4-thiadiazole derivatives as dual analgesic/anti-inflammatory and antimicrobial agents. Lett. Drug Des. Discov. 2012 9 2 204 212 10.2174/157018012799079626
    [Google Scholar]
  71. Palaska E. Şahin G. Kelicen P. Durlu N.T. Altinok G. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco 2002 57 2 101 107 10.1016/S0014‑827X(01)01176‑4 11902651
    [Google Scholar]
  72. Omar Y.M. Abdu-Allah H.H.M. Abdel-Moty S.G. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX. Bioorg. Chem. 2018 80 461 471 10.1016/j.bioorg.2018.06.036 29986191
    [Google Scholar]
  73. Oruç E.E. Rollas S. Kandemirli F. Shvets N. Dimoglo A.S. 1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation. J. Med. Chem. 2004 47 27 6760 6767 10.1021/jm0495632 15615525
    [Google Scholar]
  74. Alegaon S.G. Alagawadi K.R. Sonkusare P.V. Chaudhary S.M. Dadwe D.H. Shah A.S. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents. Bioorg. Med. Chem. Lett. 2012 22 5 1917 1921 10.1016/j.bmcl.2012.01.052 22325950
    [Google Scholar]
  75. Quintana C. Klahn A.H. Artigas V. Fuentealba M. Biot C. Halloum I. Kremer L. Arancibia R. Cyrhetrenyl and ferrocenyl 1,3,4-thiadiazole derivatives: Synthesis, characterization, crystal structures and in vitro antitubercular activity. Inorg. Chem. Commun. 2015 55 48 50 10.1016/j.inoche.2015.03.008
    [Google Scholar]
  76. Karakuş S. Rollas S. Synthesis and antituberculosis activity of new N-phenyl-N′-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas. Farmaco 2002 57 7 577 581 10.1016/S0014‑827X(02)01252‑1 12164218
    [Google Scholar]
  77. Kolavi G. Hegde V. Khazi I. Gadad P. Synthesis and evaluation of antitubercular activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives. Bioorg. Med. Chem. 2006 14 9 3069 3080 10.1016/j.bmc.2005.12.020 16406644
    [Google Scholar]
  78. Chandra Sekhar D. Venkata Rao D.V. Tejeswara Rao A. Lav Kumar U. Jha A. Design and synthesis of 1, 3, 4-thiadiazole derivatives as novel anticancer and antitubercular agents. Russ. J. Gen. Chem. 2019 89 4 770 779 10.1134/S1070363219040224
    [Google Scholar]
  79. Talath S. Gadad A.K. Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives. Eur. J. Med. Chem. 2006 41 8 918 924 10.1016/j.ejmech.2006.03.027 16781799
    [Google Scholar]
  80. Ramprasad J. Nayak N. Dalimba U. Yogeeswari P. Sriram D. Ionic liquid-promoted one-pot synthesis of thiazole–imidazo[2,1-b][1,3,4]thiadiazole hybrids and their antitubercular activity. MedChemComm 2016 7 2 338 344 10.1039/C5MD00346F 30108749
    [Google Scholar]
  81. Foroumadi A. Mirzaei M. Shafiee A. Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives. Farmaco 2001 56 8 621 623 10.1016/S0014‑827X(01)01099‑0 11601649
    [Google Scholar]
  82. Tatar E. Küçükgüzel Ş. Karakuş S. De Clercq E. Andrei G. Snoeck R. Pannecouque C. Öktem-okullu S. Ünübol N. Kocagöz T. Kalaycı S. Synthesis and biological evaluation of some new 1,3,4-thiadiazole and 1,2,4-triazole derivatives from L-methionine as antituberculosis and antiviral agents. Marmara Pharm. J. 2015 2 19 88 102 10.12991/mpj.2015199639
    [Google Scholar]
  83. Solak N. Rollas S. Synthesis and antituberculosis activity of 2-(aryl/alkylamino)-5-(4-aminophenyl)-1,3,4-thiadiazoles and their Schiff bases. ARKIVOC 2006 2006 12 173 181 10.3998/ark.5550190.0007.c20
    [Google Scholar]
  84. Hemmateenejad B. Miri R. Jafarpour M. Tabarzad M. Foroumadi A. Multiple linear regression and principal component analysis‐based prediction of the anti‐tuberculosis activity of some 2‐aryl‐1, 3, 4‐thiadiazole derivatives. QSAR Comb. Sci. 2006 25 1 56 66 10.1002/qsar.200530006
    [Google Scholar]
  85. Joshi S.D. Manish K. Badiger A. Synthesis and evaluation of antibacterial and antitubercular activities of some novel imidazo[2,1-b][1,3,4]thiadiazole derivatives. Med. Chem. Res. 2013 22 2 869 878 10.1007/s00044‑012‑0080‑4
    [Google Scholar]
  86. Jatav V. Mishra P. Kashaw S. Stables J.P. Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur. J. Med. Chem. 2008 43 1 135 141 10.1016/j.ejmech.2007.02.004 17418452
    [Google Scholar]
  87. Yusuf M. Khan R.A. Ahmed B. Syntheses and anti-depressant activity of 5-amino-1, 3, 4-thiadiazole-2-thiol imines and thiobenzyl derivatives. Bioorg. Med. Chem. 2008 16 17 8029 8034 10.1016/j.bmc.2008.07.056 18693019
    [Google Scholar]
  88. Rzeski W. Matysiak J. Kandefer-Szerszeń M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound. Bioorg. Med. Chem. 2007 15 9 3201 3207 10.1016/j.bmc.2007.02.041 17350846
    [Google Scholar]
  89. Clerici F. Pocar D. Guido M. Loche A. Perlini V. Brufani M. Synthesis of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity. J. Med. Chem. 2001 44 6 931 936 10.1021/jm001027w 11300875
    [Google Scholar]
  90. Altıntop M. Can Ö. Demir Özkay Ü. Kaplancıklı Z. Synthesis and evaluation of new 1, 3, 4-thiadiazole derivatives as antinociceptive agents. Molecules 2016 21 8 1004 10.3390/molecules21081004 27490523
    [Google Scholar]
  91. Juszczak M. Walczak K. Langner E. Karpińska M. Matysiak J. Rzeski W. Neuroprotective activity of 2-amino-1,3,4-thiadiazole derivative 4BrABT--an in vitro study. Ann. Agric. Environ. Med. 2013 20 3 575 579 24069868
    [Google Scholar]
  92. Skrzypek A. Matysiak J. Karpińska M. Czarnecka K. Kręcisz P. Stary D. Kukułowicz J. Paw B. Bajda M. Szymański P. Niewiadomy A. Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors. Bioorg. Chem. 2021 107 104617 10.1016/j.bioorg.2020.104617 33444983
    [Google Scholar]
  93. Khan I. Hanif M. Hussain M.T. Khan A.A. Aslam M.A.S. Rama N.H. Iqbal J. Synthesis, acetylcholinesterase and alkaline phosphatase inhibition of some new 1, 2, 4-triazole and 1, 3, 4-thiadiazole derivatives. Aust. J. Chem. 2012 65 10 1413 1419 10.1071/CH12134
    [Google Scholar]
  94. Sağlık B.N. Kaya Çavuşoğlu B. Acar Çevik U. Osmaniye D. Levent S. Özkay Y. Kaplancıklı Z.A. Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors – design, synthesis, biological evaluation and molecular modelling. RSC Med. Chem. 2020 11 9 1063 1074 10.1039/D0MD00150C 33479699
    [Google Scholar]
  95. Azimi S. Firuzi O. Iraji A. Zonouzi A. Khoshneviszadeh M. Mahdavi M. Edraki N. Synthesis and in vitro biological activity evaluation of novel imidazo [2, 1-B][1, 3, 4] thiadiazole as anti-alzheimer agents. Lett. Drug Des. Discov. 2020 17 5 610 617 10.2174/1570180816666181108115510
    [Google Scholar]
  96. Sharma R. Prasad Y. Mishra G.P. Chaturvedi S.C. Some substituted 1,3,4-thiadiazoles: A novel centrally acting agents. Med. Chem. Res. 2014 23 1 252 258 10.1007/s00044‑013‑0626‑0
    [Google Scholar]
  97. Kulshreshtha A. Piplani P. Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction. Eur. J. Med. Chem. 2016 122 557 573 10.1016/j.ejmech.2016.06.046 27448914
    [Google Scholar]
/content/journals/ctmc/10.2174/0115680266344588241127031534
Loading
/content/journals/ctmc/10.2174/0115680266344588241127031534
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keywords: 1,3,4-thiadiazole ; biological activity ; review ; anti-cancer ; anti-diabetic
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test